RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.030
-0.040 (-3.74%)
Nov 21, 2024, 11:13 AM EST - Market open
RAPT Therapeutics Employees
RAPT Therapeutics had 131 employees as of December 31, 2023. The number of employees increased by 34 or 35.05% compared to the previous year.
Employees
131
Change (1Y)
34
Growth (1Y)
35.05%
Revenue / Employee
n/a
Profits / Employee
-$820,550
Market Cap
36.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Beyond Air | 107 |
Carisma Therapeutics | 107 |
Adagio Medical Holdings | 85 |
BioLineRx | 79 |
Rallybio | 43 |
Lumos Pharma | 33 |
Incannex Healthcare | 9 |
Anebulo Pharmaceuticals | 3 |
RAPT News
- 10 days ago - Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga
- 4 months ago - RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus - Seeking Alpha
- 6 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga
- 6 months ago - RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity - Seeking Alpha
- 7 months ago - RAPT Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients - GlobeNewsWire
- 8 months ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 9 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire